Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIPA | P38571 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.37 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.33 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TSHR | P16473 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | RECQL | P46063 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7132308 | 1.00 | LIPA (0.40) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL15261953 | 1.00 | LIPA (0.40) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL2568051 | 1.00 | LIPA (0.40) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL11324326 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL10452360 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL23885014 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL8189314 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL6814313 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL1297508 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA | |
| SCHEMBL143111 | 0.97 | LIPA (0.39) | LIPAGAACYP11B2CYP19A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007113650-A2 | A NOVEL AND IMPROVED PROCESS FRO THE PREPARATION OF NATEGLINIDE AND ITS POLYMORPH FORM-H | CADILA PHARMACEUTICALS LIMITED (IN) | 2007-10-11 | — | — | WO | claimed |
| EP-2157084-B1 | 5-PHENYL-3-PYRIDAZINONE DERIVATIVE | KOWA CO (JP) | 2013-05-22 | — | — | EP | disclosed |
| EP-2493906-A1 | HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2012-09-05 | — | — | EP | disclosed |
| US-8106053-B2 | 5-phenyl-3-pyridazinone derivative | KOWA COMPANY, LTD. | 2012-01-31 | — | — | US | disclosed |
| WO-2011051404-A1 | HETEROLEPTIC CARBENE COMPLEXES AND USE THEREOF IN ORGANIC ELECTRONICS | BASF SE (DE) | 2011-05-05 | — | — | WO | disclosed |
| US-20100324091-A1 | Pyrazolone Derivative | KOWA COMPANY, LTD. (JP) | 2010-12-23 | — | — | US | disclosed |
| US-20100197698-A1 | 5-PHENYL-3-PYRIDAZINONE DERIVATIVE | KOWA COMPANY, LTD. (JP) | 2010-08-05 | — | — | US | disclosed |
| EP-2172458-A1 | PYRAZOLONE DERIVATIVE | Kowa Company, Ltd. (JP) | 2010-04-07 | — | — | EP | disclosed |
| EP-2157084-A1 | 5-PHENYL-3-PYRIDAZINONE DERIVATIVE | Kowa Company, Ltd. (JP) | 2010-02-24 | — | — | EP | disclosed |
| WO-2007113650-A2 | A NOVEL AND IMPROVED PROCESS FRO THE PREPARATION OF NATEGLINIDE AND ITS POLYMORPH FORM-H | CADILA PHARMACEUTICALS LIMITED (IN) | 2007-10-11 | — | — | WO | disclosed |
| EP-0903356-B1 | CRYSTALLINE POLYPROPYLENE, PROCESS FOR PREPARING THE SAME, POLYPROPYLENE COMPOSITION, AND THERMOFORMED ARTICLE | MITSUI CHEMICALS INC (JP) | 2005-09-07 | — | — | EP | disclosed |
| WO-2004104051-A1 | BIMOLECULAR PHOTOINITIATOR SYSTEMS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2004-12-02 | — | — | WO | disclosed |
| US-6403708-B2 | THERMOFORMING | MITSUI CHEMICALS INC (JP) | 2002-06-11 | — | — | US | disclosed |
| US-20010025090-A1 | CRYSTALLINE POLYPROPYLENES, PROCESS FOR PREPARING THEROF, POLYPROPYLENE COMPOSITIONS, AND THERMOFORMED PRODUCTS | PRIME POLYMER CO., LTD. (JP) | 2001-09-27 | — | — | US | disclosed |
| EP-0903356-A1 | CRYSTALLINE POLYPROPYLENE, PROCESS FOR PREPARING THE SAME, POLYPROPYLENE COMPOSITION, AND THERMOFORMED ARTICLE | Mitsui Chemicals, Inc. (JP) | 1999-03-24 | — | — | EP | disclosed |
| EP-0112568-B1 | GLASS-REINFORCED POLYMER COMPOSITION | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1986-11-05 | — | — | EP | disclosed |
| US-3962302-A | Production of isocyanates from esters of carbamic acids (urethanes) | ATLANTIC RICHFIELD COMPANY (US) | 1976-06-08 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100197698-A1 | 5-PHENYL-3-PYRIDAZINONE DERIVATIVE | SERPINE1, MMP1, PLAT | LIPA 2541/4885GAA 2350/4885CYP11B2 1396/4885 |
| US-20100324091-A1 | Pyrazolone Derivative | SERPINE1, SERPINC1, TFPI | LIPA 3136/4885GAA 3107/4885CYP11B2 1352/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.